Malaria medicines: a glass half full? (Q38497838)

3 September 2017

1 reference

title

Malaria medicines: a glass half full? (English)

1 reference

Rob Hooft van Huijsduijnen

3 September 2017

0 references

object named as

Rob Hooft van Huijsduijnen

series ordinal

2

0 references

Timothy N C Wells

object named as

Timothy N C Wells

series ordinal

1

0 references

author name string

Wesley C Van Voorhis

series ordinal

3

1 reference

3 September 2017

publication date

22 May 2015

1 reference

Nature Reviews Drug Discovery

3 September 2017

published in

1 reference

3 September 2017

volume

14

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

424-442

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd4573

3 September 2017

exact match

0 references

cites work

The economic and social burden of malaria

1 reference

The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya

31 March 2020

1 reference

New medicines to improve control and contribute to the eradication of malaria

31 March 2020

1 reference

The global pipeline of new medicines for the control and elimination of malaria

31 March 2020

1 reference

Recent advances in malaria drug discovery

31 March 2020

1 reference

A Research Agenda to Underpin Malaria Eradication

31 March 2020

1 reference

A research agenda for malaria eradication: drugs

31 March 2020

1 reference

Designing the next generation of medicines for malaria control and eradication

31 March 2020

1 reference

Experimentally induced blood stage malaria infection as a tool for clinical research.

31 March 2020

1 reference

A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies.

31 March 2020

1 reference

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

31 March 2020

1 reference

Artemisinin Resistance in Plasmodium falciparum Malaria

31 March 2020

1 reference

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

31 March 2020

1 reference

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

31 March 2020

1 reference

Genetic architecture of artemisinin-resistant Plasmodium falciparum

31 March 2020

1 reference

Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates

31 March 2020

1 reference

Global health improvement and WHO: shaping the future

31 March 2020

1 reference

Malaria and the Millennium Development Goals

31 March 2020

1 reference

Malaria resurgence: a systematic review and assessment of its causes

31 March 2020

1 reference

Malaria control and elimination, Venezuela, 1800s –1970s.

31 March 2020

1 reference

Spread of artemisinin resistance in Plasmodium falciparum malaria

31 March 2020

1 reference

Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial

31 March 2020

1 reference

Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum

31 March 2020

1 reference

Origin and evolution of sulfadoxine resistant Plasmodium falciparum

31 March 2020

1 reference

Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance

31 March 2020

1 reference

Single low-dose primaquine to reduce malaria transmission

31 March 2020

1 reference

Neglect of Plasmodium vivax malaria

31 March 2020

1 reference

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

31 March 2020

1 reference

Single-dose radical cure of Plasmodium vivax: a step closer

31 March 2020

1 reference

High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581

31 March 2020

1 reference

Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women of eastern Sudan

31 March 2020

1 reference

Review of the malaria epidemiology and trends in Zambia

31 March 2020

1 reference

The antimalarial ferroquine: from bench to clinic

31 March 2020

1 reference

Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections

31 March 2020

1 reference

Investigation of the redox behavior of ferroquine, a new antimalarial

31 March 2020

1 reference

A Concise Synthesis of (+)-Artemisinin

31 March 2020

1 reference

A continuous-flow process for the synthesis of artemisinin

31 March 2020

1 reference

Continuous-Flow Synthesis of the Anti-Malaria Drug Artemisinin

31 March 2020

1 reference

Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial

31 March 2020

1 reference

The need for new antimalarial drugs less prone to resistance

31 March 2020

1 reference

Artemisinin resistance: current status and scenarios for containment

31 March 2020

1 reference

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia

31 March 2020

1 reference

Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo

31 March 2020

1 reference

First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone

31 March 2020

1 reference

Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins.

31 March 2020

1 reference

Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers

31 March 2020

1 reference

Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity

31 March 2020

1 reference

Drug- and non-drug-associated QT interval prolongation

31 March 2020

1 reference

Microbiology. Is the tide turning for new malaria medicines?

31 March 2020

1 reference

Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential

31 March 2020

1 reference

Structural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical Scaffolds

31 March 2020

1 reference

A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs

31 March 2020

1 reference

Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery

31 March 2020

1 reference

Thousands of chemical starting points for antimalarial lead identification

31 March 2020

1 reference

Chemical genetics of Plasmodium falciparum

31 March 2020

1 reference

The open access malaria box: a drug discovery catalyst for neglected diseases

31 March 2020

1 reference

Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum

31 March 2020

1 reference

Spiroindolones, a potent compound class for the treatment of malaria

31 March 2020

1 reference

Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria.

31 March 2020

1 reference

Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials

31 March 2020

1 reference

Expression and functional characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms

31 March 2020

1 reference

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel antimalarial Spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteer

31 March 2020

1 reference

Spiroindolone KAE609 for falciparum and vivax malaria

31 March 2020

1 reference

Trial watch: Next-generation antimalarial from phenotypic screen shows clinical promise.

31 March 2020

1 reference

Antimalarial drug discovery - approaches and progress towards new medicines.

31 March 2020

1 reference

Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum

31 March 2020

1 reference

(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.

31 March 2020

1 reference

Diverse chemotypes disrupt ion homeostasis in the Malaria parasite

31 March 2020

1 reference

3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential

31 March 2020

1 reference

Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics

31 March 2020

1 reference

Targeting Plasmodium PI(4)K to eliminate malaria

31 March 2020

1 reference

How many drug targets are there?

31 March 2020

1 reference

The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteins

31 March 2020

1 reference

European lead factory opens for business

31 March 2020

1 reference

Combinatorial compound libraries for drug discovery: an ongoing challenge

31 March 2020

1 reference

Natural products as starting points for future anti-malarial therapies: going back to our roots?

31 March 2020

1 reference

Discovering and developing new medicines for malaria control and elimination

31 March 2020

1 reference

The GHIT fund shows its cards.

31 March 2020

1 reference

The Global Health Innovative Technology (GHIT) Fund: financing medical innovations for neglected populations

31 March 2020

1 reference

Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents

31 March 2020

1 reference

Identification of inhibitors of Plasmodium falciparum gametocyte development

31 March 2020

1 reference

Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures

31 March 2020

1 reference

A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax

31 March 2020

1 reference

Experimental human influenza: observations from studies of influenza antivirals

31 March 2020

1 reference

Norwalk virus shedding after experimental human infection

31 March 2020

1 reference

Rhinovirus genome evolution during experimental human infection

31 March 2020

1 reference

Controlled human malaria infection

31 March 2020

1 reference

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity

31 March 2020

1 reference

Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers

31 March 2020

1 reference

African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping

31 March 2020

1 reference

Pharmacogenetics, pharmacogenomics, and individualized medicine

31 March 2020

1 reference

Impact of pharmacogenomics on neglected diseases of the developing world

31 March 2020

1 reference

Models for open innovation in the pharmaceutical industry

31 March 2020

1 reference

Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii

31 March 2020

1 reference

Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box

31 March 2020

1 reference

Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica

31 March 2020

1 reference

Identification of MMV Malaria Box inhibitors of Perkinsus marinus using an ATP-based bioluminescence assay

31 March 2020

1 reference

Orally active antischistosomal early leads identified from the open access malaria box

31 March 2020

1 reference

Acquired immunity to malaria

31 March 2020

1 reference

A 2020 vision for vaccines against HIV, tuberculosis and malaria

31 March 2020

1 reference

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine

31 March 2020

1 reference

Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs

31 March 2020

1 reference

Vaccine adjuvants: current state and future trends

31 March 2020

1 reference

Adjuvants for human vaccines

31 March 2020

1 reference

Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family

31 March 2020

1 reference

Plasmodium falciparum var gene expression is developmentally controlled at the level of RNA polymerase II-mediated transcription initiation

31 March 2020

1 reference

Antigenic variation in Trypanosoma brucei: joining the DOTs

31 March 2020

1 reference

MMV in partnership: the Eurartesim® experience

31 March 2020

1 reference

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

31 March 2020

1 reference

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

31 March 2020

1 reference

A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons

31 March 2020

1 reference

Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment

31 March 2020

1 reference

Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.

31 March 2020

1 reference

Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1

31 March 2020

1 reference

MK-4815, a potential new oral agent for treatment of malaria

31 March 2020

1 reference

Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse

31 March 2020

1 reference

The antimalarial trioxaquine DU1301 alkylates heme in malaria-infected mice.

31 March 2020

1 reference

Role of type-II pathway in apoptotic cell death induction by photosensitized CDRI-97/78 under ambient exposure of UV-B.

31 March 2020

1 reference

Intersex effect of lamotrigine on the pharmacokinetic parameters of CDRI-97/78, a novel trioxane antimalarial compound, in rats.

31 March 2020

1 reference

Effect of carbamazepine on the pharmacokinetic parameters of CDRI-97/78 following coadministration to rats.

31 March 2020

1 reference

Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection

31 March 2020

1 reference

Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria

31 March 2020

1 reference

Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model

31 March 2020

1 reference

KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission

31 March 2020

1 reference

Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso

31 March 2020

1 reference

Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold

31 March 2020

1 reference

First-in-humans study of the safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity

31 March 2020

1 reference

Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate

31 March 2020

1 reference

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.

31 March 2020

1 reference

Second generation analogues of RKA182: synthetic tetraoxanes with outstanding in vitro and in vivo antimalarial activities

31 March 2020

1 reference

Examination of the cytotoxic and embryotoxic potential and underlying mechanisms of next-generation synthetic trioxolane and tetraoxane antimalarials

31 March 2020

1 reference

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

31 March 2020

1 reference

Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs

31 March 2020

1 reference

Fluorine Modulates Species Selectivity in the Triazolopyrimidine Class of Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors

31 March 2020

1 reference

Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug

31 March 2020

1 reference

A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor

31 March 2020

1 reference

Investigation of indolglyoxamide and indolacetamide analogues of polyamines as antimalarial and antitrypanosomal agents

31 March 2020

1 reference

Antiparasitic effect of a fraction enriched in tight-binding protease inhibitors isolated from the Caribbean coral Plexaura homomalla

31 March 2020

1 reference

Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages

31 March 2020

1 reference

Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.

31 March 2020

1 reference

Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.

31 March 2020

1 reference

Plasmepsin Inhibitory Activity and Structure-Guided Optimization of a Potent Hydroxyethylamine-Based Antimalarial Hit

31 March 2020

1 reference

Evaluation of aminohydantoins as a novel class of antimalarial agents.

31 March 2020

1 reference

Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.

31 March 2020

1 reference

12 December 2020

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

1 reference

12 December 2020

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

1 reference

12 December 2020

Will combinatorial chemistry keep its promise?

1 reference

12 December 2020

Intermittent preventive treatment for malaria in children living in areas with seasonal transmission

1 reference

12 December 2020

Increased pyrethroid resistance in malaria vectors and decreased bed net effectiveness, Burkina Faso.

1 reference

12 December 2020

Psychiatric side effects of mefloquine: applications to forensic psychiatry.

1 reference

12 December 2020

Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug

1 reference

12 December 2020

Insecticide-treated bed nets and curtains for preventing malaria

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRD4573

1 reference

3 September 2017

1 reference